Liver transplantation is currently the only established treatment for patients with end stage liver failure. However, this treatment is limited by the shortage of donors and the conditional integrity ...
An experimental tripeptide called DT-109 reversed advanced fatty liver disease in animal models by repairing the intestinal barrier rather than targeting the liver directly. The compound, identified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results